全文获取类型
收费全文 | 49536篇 |
免费 | 3336篇 |
国内免费 | 198篇 |
专业分类
耳鼻咽喉 | 542篇 |
儿科学 | 1296篇 |
妇产科学 | 891篇 |
基础医学 | 6472篇 |
口腔科学 | 1261篇 |
临床医学 | 4821篇 |
内科学 | 10103篇 |
皮肤病学 | 732篇 |
神经病学 | 4820篇 |
特种医学 | 2601篇 |
外国民族医学 | 6篇 |
外科学 | 7332篇 |
综合类 | 597篇 |
一般理论 | 40篇 |
预防医学 | 4021篇 |
眼科学 | 1194篇 |
药学 | 2990篇 |
中国医学 | 74篇 |
肿瘤学 | 3277篇 |
出版年
2023年 | 187篇 |
2022年 | 170篇 |
2021年 | 831篇 |
2020年 | 625篇 |
2019年 | 836篇 |
2018年 | 988篇 |
2017年 | 794篇 |
2016年 | 948篇 |
2015年 | 1072篇 |
2014年 | 1516篇 |
2013年 | 2094篇 |
2012年 | 3162篇 |
2011年 | 3352篇 |
2010年 | 1909篇 |
2009年 | 1742篇 |
2008年 | 3098篇 |
2007年 | 3199篇 |
2006年 | 3134篇 |
2005年 | 3073篇 |
2004年 | 2870篇 |
2003年 | 2787篇 |
2002年 | 2683篇 |
2001年 | 628篇 |
2000年 | 591篇 |
1999年 | 666篇 |
1998年 | 604篇 |
1997年 | 472篇 |
1996年 | 431篇 |
1995年 | 413篇 |
1994年 | 326篇 |
1993年 | 295篇 |
1992年 | 391篇 |
1991年 | 362篇 |
1990年 | 329篇 |
1989年 | 336篇 |
1988年 | 298篇 |
1987年 | 316篇 |
1986年 | 292篇 |
1985年 | 311篇 |
1984年 | 305篇 |
1983年 | 299篇 |
1982年 | 310篇 |
1981年 | 290篇 |
1980年 | 255篇 |
1979年 | 224篇 |
1978年 | 235篇 |
1977年 | 196篇 |
1976年 | 165篇 |
1975年 | 184篇 |
1974年 | 185篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
1.
2.
3.
4.
5.
6.
Susanna Zanutto Chiara Maura Ciniselli Antonino Belfiore Mara Lecchi Enzo Masci Gabriele Delconte Massimo Primignani Giulia Tosetti Marco Dal Fante Linda Fazzini Aldo Airoldi Marcello Vangeli Francesca Turpini Giovanni Giuseppe Rubis Passoni Paolo Viaggi Monica Arena Roberta Ilaria Olimpia Motta Anna Maria Cantù Cristiano Crosta Giuseppe De Roberto Francesca Iannuzzi Andrea Cassinotti Valentina Dall'Olio Laura Tizzoni Gabriella Sozzi Emanuele Meroni Luigi Bisanti Marco Alessandro Pierotti Paolo Verderio Manuela Gariboldi 《International journal of cancer. Journal international du cancer》2020,146(4):1164-1173
Colorectal cancer (CRC) screening programs help diagnose cancer precursors and early cancers and help reduce CRC mortality. However, currently recommended tests, the fecal immunochemical test (FIT) and colonoscopy, have low uptake. There is therefore a pressing need for screening strategies that are minimally invasive and consequently more acceptable to patients, most likely blood based, to increase early CRC identification. MicroRNAs (miRNAs) released from cancer cells are detectable in plasma in a remarkably stable form, making them ideal cancer biomarkers. Using plasma samples from FIT-positive (FIT+) subjects in an Italian CRC screening program, we aimed to identify plasma circulating miRNAs that detect early CRC. miRNAs were initially investigated by quantitative real-time PCR in plasma from 60 FIT+ subjects undergoing colonoscopy at Fondazione IRCCS Istituto Nazionale dei Tumori, then tested on an internal validation cohort (IVC, 201 cases) and finally in a large multicenter prospective series (external validation cohort [EVC], 1121 cases). For each endoscopic lesion (low-grade adenoma [LgA], high-grade adenoma [HgA], cancer lesion [CL]), specific signatures were identified in the IVC and confirmed on the EVC. A two-miRNA-based signature for CL and six-miRNA signatures for LgA and HgA were selected. In a multivariate analysis including sex and age at blood collection, the areas under the receiver operating characteristic curve (95% confidence interval) of the signatures were 0.644 (0.607–0.682), 0.670 (0.626–0.714) and 0.682 (0.580–0.785) for LgA, HgA and CL, respectively. A miRNA-based test could be introduced into the FIT+ workflow of CRC screening programs so as to schedule colonoscopies only for subjects likely to benefit most. 相似文献
7.
8.
9.
10.
J. Savige L. Amos Frank Ierino H. G. Mack R. C. Andrew Symons P. Hughes 《Ophthalmic genetics》2016,37(4):369-376
Background: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Factor H (CFH) mutations. This study describes the retinal abnormalities in dense deposit disease and, for the first time, atypical haemolytic uremic syndrome. It also reviews our understanding of drusen pathogenesis and their relevance for glomerular disease. Methods: Six individuals with dense deposit disease and one with atypical haemolytic uremic syndrome were studied from 2 to 40 years after presentation. Five had renal transplants. All four who had genetic testing had CFH mutations. Individuals underwent ophthalmological review and retinal photography, and in some cases, optical coherence tomography, and further tests of retinal function. Results: All subjects with dense deposit disease had impaired night vision and retinal drusen or whitish-yellow deposits. Retinal atrophy, pigmentation, and hemorrhage were common. In late disease, peripheral vision was restricted, central vision was distorted, and there were scotoma from sub-retinal choroidal neovascular membranes and atypical serous retinopathy. Drusen were present but less prominent in the young person with atypical uremic syndrome due to a heterozygous CFH mutation. Conclusions: Drusen are common in forms of C3 glomerulopathy caused by compound heterozygous or heterozygous CFH mutations. They are useful diagnostically but also impair vision. Drusen have an identical composition to glomerular deposits. They are also identical to the drusen of age-related macular degeneration, and may respond to the same treatments. Individuals with a C3 glomerulopathy should be assessed ophthalmologically at diagnosis, and monitored regularly for vision-threatening complications. 相似文献